newsfilter
← Latest News
GlobeNewswire·

UroGen Pharma to Present at the Guggenheim Securities Emerging Outlook: Biotech Summit

PRINCETON, N.J., Feb. 04, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (NASDAQ:URGN), a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today